State Board of Administration of Florida Retirement System’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$483K Buy
7,677
+227
+3% +$14.5K ﹤0.01% 1615
2026
Q1
$523K Hold
7,450
﹤0.01% 1504
2025
Q4
$610K Hold
7,450
﹤0.01% 1444
2025
Q3
$443K Hold
7,450
﹤0.01% 1601
2025
Q2
$302K Hold
7,450
﹤0.01% 1739
2025
Q1
$383K Hold
7,450
﹤0.01% 1601
2024
Q4
$413K Hold
7,450
﹤0.01% 1622
2024
Q3
$245K Hold
7,450
﹤0.01% 1895
2024
Q2
$202K Buy
+7,450
New +$251K ﹤0.01% 1948
2022
Q4
Sell
-13,170
Closed -$225K 2328
2022
Q3
$225K Hold
13,170
﹤0.01% 2015
2022
Q2
$192K Buy
+13,170
New +$198K ﹤0.01% 2124

Other funds holding TARS

State Board of Administration of Florida Retirement System's TARS Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System increased its Tarsus Pharmaceuticals (TARS) stake by 3% in Q2 2026, buying an estimated $14.5K and bringing the position to 7,677 shares worth $483K. The position accounts for ﹤0.01% of the portfolio, ranked #1615.

State Board of Administration of Florida Retirement System first reported a position in TARS in Q2 2022 and has held it in 11 quarters since. The position peaked at $610K in Q4 2025. 93 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 7,677 shares of Tarsus Pharmaceuticals worth $483K as of Q2 2026.
  • State Board of Administration of Florida Retirement System bought 227 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $14.5K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1615 holding.
  • State Board of Administration of Florida Retirement System first reported a position in Tarsus Pharmaceuticals in Q2 2022 and has held it in 11 quarters since.
  • State Board of Administration of Florida Retirement System's Tarsus Pharmaceuticals position peaked at $610K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.